iBio, Inc. (IBIO)
NYSEAMERICAN: IBIO · IEX Real-Time Price · USD
1.950
-0.060 (-2.99%)
Jul 2, 2024, 4:00 PM EDT - Market closed
iBio, Inc. Market Cap
iBio, Inc. has a market cap or net worth of $16.82 million as of July 2, 2024. Its market cap has increased by 47.51% in one year.
Market Cap
16.82M
Enterprise Value
28.34M
1-Year Change
47.51%
Ranking
Category
Stock Price
$1.95
Market Cap Chart
Since November 16, 2009, iBio, Inc.'s market cap has decreased from $27.70M to $16.82M, a decrease of -39.29%. That is a compound annual growth rate of -3.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 16.80M | 784.21% |
| Dec 29, 2023 | 1.90M | -52.50% |
| Dec 30, 2022 | 4.00M | -96.66% |
| Dec 31, 2021 | 119.70M | -37.40% |
| Dec 31, 2020 | 191.20M | 2,320.25% |
| Dec 31, 2019 | 7.90M | -43.57% |
| Dec 31, 2018 | 14.00M | -14.63% |
| Dec 29, 2017 | 16.40M | -53.41% |
| Dec 30, 2016 | 35.20M | -18.71% |
| Dec 31, 2015 | 43.30M | -12.17% |
| Dec 31, 2014 | 49.30M | 128.24% |
| Dec 31, 2013 | 21.60M | -27.03% |
| Dec 31, 2012 | 29.60M | 10.04% |
| Dec 30, 2011 | 26.90M | -73.23% |
| Dec 31, 2010 | 100.50M | 298.81% |
| Dec 31, 2009 | 25.20M | -9.03% |
View and export this data all the way back to 2009.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lumos Pharma | 18.83M |
| Akso Health Group | 18.74M |
| TherapeuticsMD | 18.57M |
| Aspira Women's Health | 18.55M |
| NeurAxis | 18.48M |
| GlycoMimetics | 18.15M |
| Indaptus Therapeutics | 18.10M |
| Autonomix Medical | 18.09M |